שווי הפעילות העסקית: Xenon Corp (XENE)
This chart of Xenon Pharmaceuticals (XENE) quotes on GURU.Markets demonstrates an Enterprise Value of 2594.91. Xenon Pharmaceuticals (XENE) operates through Canadian R&D centers, outsourcing drug manufacturing to third-party contractors. Operational continuity is ensured by strictly controlled, specialized transportation of components. The success of this epilepsy treatment developer is directly determined by test results and approval from relevant regulatory authorities.
%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A4%D7%A2%D7%99%D7%9C%D7%95%D7%AA&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261029&filename=GURU_Markets_-_XENE_-_Xenon-Pharmaceuticals_-_Enterprise-Value "Xenon - שווי פירמה כולל XENE (תקופה 23.11.2025 - 29.10.2026) | 👁️GURU.Markets👁️")
Xenon Pharmaceuticals - פילוחים אנליטיים ומדדי מפתח (XENE)
Xenon Pharmaceuticals (XENE) investments in laboratory greening and renewable energy require strict control of capital expenditures. Enterprise Value (EV) sums market capitalization and net debt, allowing an investor to determine the actual acquisition cost of the company accounting for all liabilities and cash reserves, which is reflected in the price action of this enterprise value.